Sign Up
Stories
Amgen to Lay Off Horizon Employees After $28B Acquisition
Share
Amgen and Pfizer Complete Acquisitions b...
Biotech Acquisitions & Layoffs
Cigna Explores Selling Medicare Advantag...
Assure Holdings Corp. Merges with Danam ...
BioRestorative Therapies Inc (BRTX) Stoc...
COVID-19 Diagnostics and Gene Therapy Re...
Overview
API
Amgen, a California biotech company, plans to lay off 350 Horizon Therapeutics employees after acquiring the Irish drugmaker for $28 billion. The acquisition brings Amgen's portfolio of rare and immune disease drugs, which generated $3.6 billion in sales last year.
Ask a question
How will the acquisition of Horizon Therapeutics impact Amgen's portfolio and sales?
What are the reasons behind Amgen's decision to lay off Horizon employees?
What measures is Amgen taking to ensure the continued service of patients with rare diseases?
Article Frequency
0.2
0.4
0.6
0.8
1.0
May 2023
Jun 2023
Jul 2023
Aug 2023
Sep 2023
Coverage